German speaking Arthroscopy Registry

German speaking Arthroscopy Registry - DART

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012994

Enrollment

5000

Registered

2018-01-09

Start date

2017-11-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S40-S49 S50-S59 S60-S69 S70-S79 S80-S89 S90-S99 T00-T07 T80-T88 M00-M25 M80-M94 M95-M99

Interventions

Group 1: The arthroscopic procedure will be performed as part of the routine management. Suitable patients will be informed by the surgeon. After the patient has given informed consent medical data wi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Male and female patients aged = 18 years - Patients with arthroscopic joint surgery of the knee, hip, ankle or shoulder - Patients who give their written informed consent - Patients who are able to understand the nature, significance and consequences of the trial - Patients with a valid e-mailaddress

Exclusion criteria

Exclusion criteria: No exclusion criteria specified

Design outcomes

Secondary

Measure	Time frame
Secondary outcomes knee: KOOS after 6, 12, 36, 60 and 120 months, VAS (Visual Analogue Scale) after 6, 12, 24, 36, 60 and 120 months, EQ5D (health-related quality of life questionnaire) after 6, 12, 24, 36, 60 and 120 months, Marx Score (Marx Activity Rating Scale) after 6, 12, 36, 60 and 120 months Secondary outcomes hip joint: iHot 12 after 6, 12, 36, 60 and 120 months, VAS after 6, 12, 24, 36, 60 and 120 months, EQ5D after 6, 12, 24, 36, 60 and 120 months, Marx score after 6, 12, 36, 60 and 120 months. Secondary outcomes ankle joint: FAAM after 6, 12, 36, 60 and 120 months, VAS after 6, 12, 24, 36, 60 and 120 months, EQ5D after 6, 12, 24, 36, 60 and 120 months, Marx score after 6, 12, 36, 60 and 120 months. Secondary outcomes shoulder: Oxford Shoulder Score or ASES after 6, 12, 36, 60 and 120 months, VAS after 6, 12, 24, 36, 60 and 120 months, EQ5D after 6, 12, 24, 36, 60 and 120 months, Marx Score after 6, 12, 36, 60 and 120 months	—

Measure

Time frame

Secondary outcomes knee: KOOS after 6, 12, 36, 60 and 120 months, VAS (Visual Analogue Scale) after 6, 12, 24, 36, 60 and 120 months, EQ5D (health-related quality of life questionnaire) after 6, 12, 24, 36, 60 and 120 months, Marx Score (Marx Activity Rating Scale) after 6, 12, 36, 60 and 120 months Secondary outcomes hip joint: iHot 12 after 6, 12, 36, 60 and 120 months, VAS after 6, 12, 24, 36, 60 and 120 months, EQ5D after 6, 12, 24, 36, 60 and 120 months, Marx score after 6, 12, 36, 60 and 120 months. Secondary outcomes ankle joint: FAAM after 6, 12, 36, 60 and 120 months, VAS after 6, 12, 24, 36, 60 and 120 months, EQ5D after 6, 12, 24, 36, 60 and 120 months, Marx score after 6, 12, 36, 60 and 120 months. Secondary outcomes shoulder: Oxford Shoulder Score or ASES after 6, 12, 36, 60 and 120 months, VAS after 6, 12, 24, 36, 60 and 120 months, EQ5D after 6, 12, 24, 36, 60 and 120 months, Marx Score after 6, 12, 36, 60 and 120 months

—

Primary

Measure	Time frame
Primary outcome knee: Therapy response defined as reduction of 8 or more points in the KOOS (knee injury and osteoarthritis outcome score) after 24 months. Primary outcome hip joint: iHot 12 (International Hip Outcome Tool, short version) after 24 months Primary outcome ankle joint: Therapy response defined as reduction of 8 or more points in FAAM (Foot and Ankle Ability Measure) after 24 months. Primary outcome shoulder: Therapy response defined as reduction of 12 or more points in American Shoulder and Elbow Surgeon's Standardized Shoulder Assessment Form (ASES) for RM rupture and 9 points or more for prostheses.	—

Measure

Time frame

Primary outcome knee: Therapy response defined as reduction of 8 or more points in the KOOS (knee injury and osteoarthritis outcome score) after 24 months. Primary outcome hip joint: iHot 12 (International Hip Outcome Tool, short version) after 24 months Primary outcome ankle joint: Therapy response defined as reduction of 8 or more points in FAAM (Foot and Ankle Ability Measure) after 24 months. Primary outcome shoulder: Therapy response defined as reduction of 12 or more points in American Shoulder and Elbow Surgeon's Standardized Shoulder Assessment Form (ASES) for RM rupture and 9 points or more for prostheses.

—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactRalf Müller-Rath

Deutschsprachiges Arthroskopieregister gGmbH (DART gGmbH)

office@arthroskopieregister.de+49 2131 51 257 22

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026